-
Treatment with natalizumab and ocrelizumab in multiple sclerosis: The road towards a personalized approach
Toorop, A. A., 24 Nov 2023, 279 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 others , 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.Research output: Contribution to journal › Article › Academic
-
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
Toorop, A. A., van Kempen, Z. L. E., Steenhuis, M., Nielsen, J., Sinnige, L. G. F., van Dijk, G., Roosendaal, C. M., Arnoldus, E. P. J., Hoitsma, E., Lissenberg-Witte, B. I., de Jong, B. A., Oosten, B. W. V., Strijbis, E. M. M., Uitdehaag, B. M. J., Rispens, T. & Killestein, J., 1 Jun 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 482-486 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications